PortfoliosBlogForexClubs Forum Groups  Login      Registrarse    



IBEX 13,875 -1.52% sube  
EUROSTOXX50 5,273 -1.63% sube  
FTSE 8,847 -0.42% sube  
DAX 23,447 -1.37% sube  
   



Bolsia.com lets you create your portfolio of major global markets: S&P 500, FTSE 100, CAC 30, IBEX 35, DAX ... After you have created your portfolio you can compete with other users for prizes, and all users will sign up through another, so, you will be able to win the same prized won by someone you referred.

  BolsiaCoins 0 Bolsiacoins  $lIbxlmuUsTxZAt
 # HealthcareN Portfolio       Currency:EURTop 25: 1977
Visit HealthcareN
Look
Start:06/08/2024 Day Return:
0.20%
Day Rank:286
Days: 371 Month Return:
-1.72%
Month Rank:1579
Last:2025-02-10 Year Return:
0.00%
Year Rank:1975
Visits:268 All Time Return:
-12.97%
All Time Rank:1973


 JanFebMarAprMayJunJulAugSepOctNovDec Year S&P500
2024
    
    
    
    
    
-3.00%
7.53%
2.06%
1.06%
-3.16%
6.07%
-4.06%
6.02%
9.82%
2025
4.91%
-9.62%
-6.60%
-4.99%
-0.73%
-1.56%
    
    
    
    
    
    
-17.78%
1.75%

 # Stocks & Cash
Date  Amount      Ticker       % Day   Buy   Last Quote  Value % Return Weight
06/10/202475ALGN Align Technology-0.37%$247.41$181.01$13,576-26.84%13.50%
06/11/2024102ALNY Alnylam Pharmaceuticals, Inc.5.27%$156.61$165.73$16,9045.83%16.81%
06/10/2024166COO The Cooper Companies, Inc.-1.64%$94.75$69.71$11,572-26.42%11.50%
06/10/2024125ILMN Illumina, Inc.-0.42%$109.92$87.76$10,970-20.16%10.91%
06/10/202449MOH Molina Healthcare, Inc.0.79%$308.14$295.79$14,494-4.01%14.41%
06/10/202465STE STERIS plc0.38%$225.15$243.34$15,8178.08%15.72%
06/10/202442WAT Waters Corp-0.55%$300.55$347.65$14,60115.67%14.52%
06/10/20242,302Cash   0.00%1.00€1.00€2,302€0.00%2.64%
EUR/USD: 1.15391    GBP/EUR: 1.1800 Portfolio Value: $100,590 87,174€ 100%

 # PerformanceHealthcareNS&P500
Return:
-12.83%
11.74%
Annualized Return:-12.60%11.51%
Std (Volatility):20.0717.29
Sharpe:-0.830.43
Beta:0.251.00
Jensen Alpha:-1.850.00
Drawdown:25.1718.46



Suscríbete a la lista de correo del Fondo Bolsia, para recibir información sobre el posible lanzamiento, backtest de rentabilidades y toda la información relativa.

* indicates required
Email Format












x
Esta web utiliza cookies. Mas Info. Estoy de Acuerdo